GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (STU:NPAU) » Definitions » Shiller PE Ratio

BetterLife Pharma (STU:NPAU) Shiller PE Ratio : (As of Jun. 07, 2024)


View and export this data going back to 2018. Start your Free Trial

What is BetterLife Pharma Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


BetterLife Pharma Shiller PE Ratio Historical Data

The historical data trend for BetterLife Pharma's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BetterLife Pharma Shiller PE Ratio Chart

BetterLife Pharma Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BetterLife Pharma Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BetterLife Pharma's Shiller PE Ratio

For the Biotechnology subindustry, BetterLife Pharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BetterLife Pharma's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BetterLife Pharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BetterLife Pharma's Shiller PE Ratio falls into.



BetterLife Pharma Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

BetterLife Pharma's E10 for the quarter that ended in Jan. 2024 is calculated as:

For example, BetterLife Pharma's adjusted earnings per share data for the three months ended in Jan. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jan. 2024 (Change)*Current CPI (Jan. 2024)
=-0.007/125.0724*125.0724
=-0.007

Current CPI (Jan. 2024) = 125.0724.

BetterLife Pharma Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201404 0.066 98.920 0.083
201407 -0.022 99.315 -0.028
201410 -0.102 99.473 -0.128
201501 -0.831 98.209 -1.058
201504 -0.180 99.710 -0.226
201507 -0.276 100.579 -0.343
201510 -0.001 100.500 -0.001
201601 -0.754 100.184 -0.941
201604 -0.345 101.370 -0.426
201607 -0.181 101.844 -0.222
201610 -0.092 102.002 -0.113
201701 -0.078 102.318 -0.095
201704 -0.040 103.029 -0.049
201707 -0.001 103.029 -0.001
201710 0.087 103.424 0.105
201801 -0.026 104.056 -0.031
201804 -0.192 105.320 -0.228
201807 -0.130 106.110 -0.153
201810 -0.268 105.952 -0.316
201901 -0.086 105.557 -0.102
201904 -0.126 107.453 -0.147
201907 -0.191 108.243 -0.221
201910 -0.103 107.927 -0.119
202001 -0.468 108.085 -0.542
202004 0.002 107.216 0.002
202007 -0.058 108.401 -0.067
202010 -0.161 108.638 -0.185
202101 -0.345 109.192 -0.395
202104 -0.027 110.851 -0.030
202107 -0.034 112.431 -0.038
202110 -0.021 113.695 -0.023
202201 -0.035 114.801 -0.038
202204 -0.029 118.357 -0.031
202207 -0.008 120.964 -0.008
202210 -0.037 121.517 -0.038
202301 0.000 121.596 0.000
202304 -0.007 123.571 -0.007
202307 -0.007 124.914 -0.007
202310 -0.001 125.310 -0.001
202401 -0.007 125.072 -0.007

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BetterLife Pharma  (STU:NPAU) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


BetterLife Pharma Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of BetterLife Pharma's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BetterLife Pharma (STU:NPAU) Business Description

Traded in Other Exchanges
Address
1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.

BetterLife Pharma (STU:NPAU) Headlines

No Headlines